54 related articles for article (PubMed ID: 8805620)
1. Phosphatidylinositol 3 kinase activity is not essential for B7-1-mediated costimulation of proliferation or development of cytotoxicity in murine T cells.
Ni HT; Deeths MJ; Mescher MF
J Immunol; 1996 Sep; 157(6):2243-6. PubMed ID: 8805620
[TBL] [Abstract][Full Text] [Related]
2. Comparison of CD28-B7.1 and B7.2 functional interaction in resting human T cells: phosphatidylinositol 3-kinase association to CD28 and cytokine production.
Ghiotto-Ragueneau M; Battifora M; Truneh A; Waterfield MD; Olive D
Eur J Immunol; 1996 Jan; 26(1):34-41. PubMed ID: 8566081
[TBL] [Abstract][Full Text] [Related]
3. B7-1-dependent co-stimulation results in qualitatively and quantitatively different responses by CD4+ and CD8+ T cells.
Deeths MJ; Mescher MF
Eur J Immunol; 1997 Mar; 27(3):598-608. PubMed ID: 9079798
[TBL] [Abstract][Full Text] [Related]
4. CD28-dependent killing by human YT cells requires phosphatidylinositol 3-kinase activation.
Lu Y; Rodriguez R; Bjorndahl J; Phillips CA; Trevillyan JM
Eur J Immunol; 1996 Jun; 26(6):1278-84. PubMed ID: 8647205
[TBL] [Abstract][Full Text] [Related]
5. Wortmannin, a phosphatidylinositol 3-kinase inhibitor, blocks antigen-mediated, but not CD3 monoclonal antibody-induced, activation of murine CD4+ T cells.
Shi J; Cinek T; Truitt KE; Imboden JB
J Immunol; 1997 May; 158(10):4688-95. PubMed ID: 9144481
[TBL] [Abstract][Full Text] [Related]
6. Signaling pathways activated by leukocyte function-associated Ag-1-dependent costimulation.
Ni HT; Deeths MJ; Li W; Mueller DL; Mescher MF
J Immunol; 1999 May; 162(9):5183-9. PubMed ID: 10227991
[TBL] [Abstract][Full Text] [Related]
7. Differential coupling of second signals for cytotoxicity and proliferation in CD8+ T cell effectors: amplification of the lytic potential by B7.
Krummel MF; Heath WR; Allison J
J Immunol; 1999 Sep; 163(6):2999-3006. PubMed ID: 10477562
[TBL] [Abstract][Full Text] [Related]
8. Phosphatidylinositol 3-kinase activity is not essential for CD28 costimulatory activity in Jurkat T cells: studies with a selective inhibitor, wortmannin.
Lu Y; Phillips CA; Trevillyan JM
Eur J Immunol; 1995 Feb; 25(2):533-7. PubMed ID: 7875216
[TBL] [Abstract][Full Text] [Related]
9. CD28 delivers costimulatory signals independently of its association with phosphatidylinositol 3-kinase.
Truitt KE; Shi J; Gibson S; Segal LG; Mills GB; Imboden JB
J Immunol; 1995 Nov; 155(10):4702-10. PubMed ID: 7594470
[TBL] [Abstract][Full Text] [Related]
10. The role of B7-1 and B7-2 costimulation for the generation of CTL responses in vivo.
Sigal LJ; Reiser H; Rock KL
J Immunol; 1998 Sep; 161(6):2740-5. PubMed ID: 9743331
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of CD28-mediated T cell costimulation by the phosphoinositide 3-kinase inhibitor wortmannin.
Ward SG; Wilson A; Turner L; Westwick J; Sansom DM
Eur J Immunol; 1995 Feb; 25(2):526-32. PubMed ID: 7875215
[TBL] [Abstract][Full Text] [Related]
12. The capacity of the natural ligands for CD28 to drive IL-4 expression in naïve and antigen-primed CD4+ and CD8+ T cells.
Bian Y; Hiraoka S; Tomura M; Zhou XY; Yashiro-Ohtani Y; Mori Y; Shimizu J; Ono S; Dunussi-Joannopoulos K; Wolf S; Fujiwara H
Int Immunol; 2005 Jan; 17(1):73-83. PubMed ID: 15569772
[TBL] [Abstract][Full Text] [Related]
13. B7.1 costimulation increases T-cell proliferation and cytotoxicity via selective expansion of specific variable alpha and beta genes of the T-cell receptor.
Chan AK; Goedegebuure PS; von Bernstorff W; Carritte AL; Chung M; Stewart RA; Montgomery L; Spanjaard RA; McKenzie AB; Eberlein TJ
Surgery; 2000 Mar; 127(3):342-50. PubMed ID: 10715992
[TBL] [Abstract][Full Text] [Related]
14. T-cell activation by recombinant receptors: CD28 costimulation is required for interleukin 2 secretion and receptor-mediated T-cell proliferation but does not affect receptor-mediated target cell lysis.
Hombach A; Sent D; Schneider C; Heuser C; Koch D; Pohl C; Seliger B; Abken H
Cancer Res; 2001 Mar; 61(5):1976-82. PubMed ID: 11280755
[TBL] [Abstract][Full Text] [Related]
15. Costimulatory signals through B7.1/CD28 prevent T cell apoptosis during target cell lysis.
Daniel PT; Kroidl A; Cayeux S; Bargou R; Blankenstein T; Dörken B
J Immunol; 1997 Oct; 159(8):3808-15. PubMed ID: 9378968
[TBL] [Abstract][Full Text] [Related]
16. Binding of phosphatidylinositol-3-OH kinase to CD28 is required for T-cell signalling.
Pagès F; Ragueneau M; Rottapel R; Truneh A; Nunes J; Imbert J; Olive D
Nature; 1994 May; 369(6478):327-9. PubMed ID: 8183372
[TBL] [Abstract][Full Text] [Related]
17. Antigen recognition and allogeneic tumor rejection in CD8+ TCR transgenic/RAG(-/-) mice.
Manning TC; Rund LA; Gruber MM; Fallarino F; Gajewski TF; Kranz DM
J Immunol; 1997 Nov; 159(10):4665-75. PubMed ID: 9366389
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-12 can replace CD28-dependent T-cell costimulation during nonspecific cytotoxic T lymphocyte induction by anti-CD3 antibody.
Makrigiannis AP; Musgrave BL; Haeryfar SM; Hoskin DW
J Leukoc Biol; 2001 Jan; 69(1):113-22. PubMed ID: 11200055
[TBL] [Abstract][Full Text] [Related]
19. Murine TRAIL (TNF-related apoptosis inducing ligand) expression induced by T cell activation is blocked by rapamycin, cyclosporin A, and inhibitors of phosphatidylinositol 3-kinase, protein kinase C, and protein tyrosine kinases: evidence for TRAIL induction via the T cell receptor signaling pathway.
Musgrave BL; Phu T; Butler JJ; Makrigiannis AP; Hoskin DW
Exp Cell Res; 1999 Oct; 252(1):96-103. PubMed ID: 10502402
[TBL] [Abstract][Full Text] [Related]
20. MRC OX-2 defines a novel T cell costimulatory pathway.
Borriello F; Lederer J; Scott S; Sharpe AH
J Immunol; 1997 May; 158(10):4548-54. PubMed ID: 9144466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
